The Scientific Advisory Board of the Michelson Prize & Grants in Reproductive Biology has gained three new members: Drs. Thomas Conlon, Kevin Morris, and Marcel Van Duin.
Thomas Conlon, PhD, is an Assistant Professor in Pediatrics and the Director of the Powell Gene Therapy Center Toxicology Core at the University of Florida. As the Director of the Toxicology Core, Dr. Conlon facilitates efficient, cost-effective, and rigorous preclinical testing of gene therapy vectors, with a special emphasis on recombinant adeno-associated virus (rAAV) vectors. Dr. Conlon has also collaborated with the University of Florida College of Veterinary Medicine to identify and treat two types of cardiac problems experienced in dogs.
Kevin Morris, PhD, has been actively involved in cancer research in both academic and biotechnology environments for over 20 years. He has served as the Principal Investigator on a wide range of studies in animal sheltering, pet overpopulation, and the field of human-animal interaction. Dr. Morris is currently serving as the Co-Principal Investigator on the American Humane Association’s Canines and Childhood Cancer Study and is also a member of the Board of Directors of the Alliance for Contraception in Cats and Dogs (ACC&D).
Marcel Van Duin, PhD, is the Senior Director, Therapeutic Area Head Reproductive Health Research at the Ferring Research Institute in San Diego, CA. Dr. Van Duin has over 25 years’ experience in various leadership positions in the pharmaceutical industry, including as the Head of Pharmacology at Organon Research in Newhouse, Scotland, where he was responsible for all pharmacological research in the areas of reproductive biology, oncology, immunology, and toxicology, as well as the animal research facilities.
Says Dr. Gary Michelson, the founder of the Found Animals Foundation, “I am delighted to welcome Drs. Conlon, Morris and Van Duin to the Scientific Advisory Board. Their expertise in gene therapy, molecular biology and reproductive biology strengthen our Board.”
These newest members join nineteen other elite experts in the fields of reproductive biology, neuroscience, veterinary medicine, immunology, and toxicology on the Scientific Advisory Board. As a group, they review grant proposals and guide the Michelson Prize & Grants program toward our goal of finding a nonsurgical sterilant for use in male and female cats and dogs.
We are very excited to welcome these new board members to the fold and look forward to the exciting new projects that the Board will be reviewing in 2015!